Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study

DOI: 10.1186/s12959-018-0183-3

Keywords: Direct oral anticoagulants, Rivaroxaban, Bleeding, Drug monitoring, Pharmacogenomics, Patient safety

Full-Text   Cite this paper   Add to My Lib

Abstract:

Characteristics of rivaroxaban patient

Full-Text